Contents
Hospice skin substitute billing turns on whether the wound care belongs within the hospice’s responsibility for the terminal illness and related conditions or qualifies for separate Medicare coverage as unrelated care. If you work in hospice, wound care or health care billing, you may see the treatment without seeing the outside claim, or the claim without seeing the hospice’s plan. A provider can call a wound unrelated on a bill while the clinical records tell a different story.
The Centers for Medicare & Medicaid Services identified a striking increase in ulcer claims paid outside the hospice benefit during hospice elections. In its fiscal year 2027 hospice rule, the agency reported that carrier claims for ulcers, largely associated with skin substitutes, rose from $18 million in fiscal year 2020 to $714 million in fiscal year 2024.
That spending sits beside a benefit that already pays the hospice to take responsibility for related care. The useful question for a hospice billing employee is which wound services Medicare paid for separately and why the hospice considered them outside its responsibility.
The wider market makes that question more pressing. In its September 2025 skin-substitute review, the Department of Health and Human Services’ Office of Inspector General reported that annual Medicare Part B spending had surpassed $10 billion by the end of 2024. Both increased use and higher prices drove the growth. Among enrollees with a skin-substitute claim, costs for those reportedly treated at home were four times those for patients treated in an office.
The Inspector General also identified financial incentives, including spread pricing that makes some products more attractive to providers, as possible drivers. The report puts product choice, price and treatment setting alongside the patient’s wound as questions worth examining.
The hospice takes responsibility for care related to the terminal illness and related conditions, including nursing and medical supplies. Medicare pays the hospice a daily rate, and the hospice bears the cost of that related care. The payment comes for each enrolled day, including days when staff do not visit.
So calling a wound unrelated is worth money to the hospice. When Medicare pays an outside bill for care already covered by the hospice daily payment, taxpayers pay twice for the same care. The broader hospice billing problem is whether the services and claims match what Medicare has already paid the hospice to provide.
The terminal diagnosis is only where it starts. Hospice responsibility also reaches related conditions. For a wound-care insider, the important clinical account is how the wound fits into the patient’s condition, what treatment the team planned and why an outside provider considered its service separately payable.
The hospice election leaves Medicare coverage for genuinely unrelated care in place. It also preserves separate payment for an independent attending physician’s own professional services.
The Centers for Medicare & Medicaid Services takes a broad view of the care hospice must supply. Its election rules require the hospice to explain that unrelated services are exceptional and unusual. In an inquiry into hospice fraud, the clinical explanation for separating the wound from the terminal illness matters more than the convenience of sending the bill elsewhere.
For hospice skin substitute claims outside hospice benefit coverage, we compare the wound, the care plan and why the provider called the treatment unrelated. The outside claim supplies a billing account. The clinical records supply the account of what the patient needed and received.
For a hospice wound care graft billed for an unrelated condition, Medicare coverage turns on that relationship as well as the service’s own coverage requirements. The Inspector General describes Part B coverage of skin substitutes as requiring that they be reasonable and necessary for the patient’s condition. In reviewing a possible case, we examine the explanation for treating the wound, the product used and the reason for billing outside hospice together.
We follow the same patient through both sets of records with the person who knows the work behind the entries. The hospice election dates establish when the benefit was in place. The assessment and care plan describe the patient’s needs and planned services. We compare those with the provider, service date, diagnosis, product and quantity on the outside claim, and with the treatment notes for that date.
There is a coordination question too. Who knew the outside provider was treating the wound? What did the hospice physician and care team understand about the treatment? Was the outside service reflected in the plan, and how did the hospice account for its cost? Those are questions a wound nurse, facility employee and billing specialist may each answer from a different part of the patient’s care.
The clinical detail deserves attention in its own right. In Hospice Deficiencies Pose Risks to Medicare Beneficiaries, published by the Office of Inspector General in July 2019, survey findings included a hospice that failed to measure a severe pressure ulcer for several weeks, despite its policy requiring weekly measurement. It also failed to follow the physician’s wound-treatment orders. For someone examining a wound bill, the assessment, orders and actual care are the substance behind the charge.
For hospice elections beginning on or after October 1, 2026, the hospice must provide an election statement addendum identifying the conditions, items, services and drugs it considers unrelated and will not cover. The change makes the hospice put its coverage decisions in writing without waiting for a request.
For a skin-substitute billing inquiry, that document supplies the hospice’s stated position on what belongs outside its care. We compare it with the wound assessment, physician orders, care plan and outside claim. If those documents describe the same wound differently, the question becomes who made the decision and what clinical information they used.
The addendum also gives the inquiry a date. What did the hospice say it would exclude when the patient elected care, and what did it later bill or arrange? The Centers for Medicare & Medicaid Services adopted the mandatory addendum amid its concern about growing non-hospice spending. A written decision gives the patient and the people reviewing the bills something specific to compare with the care.
Knowingly shifting hospice-covered supplies onto separate Medicare claims can put the payment and the decision behind it at the center of a False Claims Act case. The clinical relationship, hospice responsibility and outside bill have to meet in the same patient episode.
The Government Accountability Office’s June 2026 hospice report cites an Inspector General finding that 42% of non-hospice spending was related to the terminal illness and should not have been paid separately.
Evidence of a knowing false claim connects the patient’s condition, the service, the bill and what the people directing the billing knew. We look for the clinical explanation behind the unrelated-care decision, the claims it affected, and instructions or internal findings showing why billing continued.
The VITAS continuous home care allegations illustrate the comparison between wound care and billing. A whistleblower alleged that a patient placed on that intensive level of hospice care needed a daily dressing change:
The dressing change was for a very small wound on his right foot, the size of a pinhead.
In its own pleading, the government alleged that a VITAS internal review found only 10% of crisis-care claims at its San Fernando program matched patients’ care plans. The allegation connected the clinical record, the level billed and the company’s own review.
For skin substitutes, we make the corresponding comparison between the wound assessment, the hospice’s related-care responsibility and the outside product claim. An internal warning can supply the next connection: who understood the problem and what they instructed staff to do about it. That is where a hospice whistleblower’s firsthand knowledge can take an inquiry beyond a spending trend. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know how the wound care, the hospice plan and the outside claims fit together, speak with our whistleblower experts about the billing decisions you have seen. We work beside you to connect the clinical facts, the payments and the people who directed them into your strongest hospice whistleblower case. We bring in healthcare fraud whistleblower lawyers who understand Medicare hospice and wound-care billing, and stay with you through the process.